Table 2.
Summary of patient parameters at baseline, treatment period and follow-up (FU)
| Treatment/ FU |
Day | 6MWT distance (metres) | FVCex (litres) | FEV1 (litres) | FEV1/FVC | Mean time to positive (hour)-liquid | Mean CFU/ mL-solid |
| Pretreatment | −134 | ND | 4.04 | 3.17 | 78 | ND | ND |
| Baseline | 0–1 | 510 | 3.84 | 3.03 | 79 | 92.5 | 9 |
| iNO | 15–16 | 504 | 3.78 | 2.91 | 77 | 132.5 | 2 |
| 28–29 | 549 | 3.58 | 2.86 | 80 | 101 | 4 | |
| FU* | 35 | ND | 4.01 | 3.22 | 80 | ND | ND |
| 69 | ND | ND | ND | ND | 95 | 4 | |
| 146 | ND | ND | ND | ND | 126.5 | 6.5 | |
| 172 | 480 | 4.34 | 3.38 | 78 | ND | ND |
*FU visits were performed at patient’s local CF-clinic.
CF, cystic fibrosis; CFU, colony-forming unit; iNO, inhaled Nitric oxide; 6MWT, 6 min walk testing; ND, not done.